share_log

港股公告掘金 | 讯飞医疗科技公开发售获3.66倍认购 全球发售净筹约5.07亿港元

Hong Kong Stock Announcement to Explore | iFlytek Medical Technology's public offering received 3.66 times subscription, with a global net raised of approximately 0.507 billion Hong Kong dollars.

Zhitong Finance ·  Dec 29, 2024 20:21

VESYNC (02148) received a privatization proposal from the acquirer VICTORY III CO., LTD through an agreement arrangement and will resume trading on December 30; ASCENTAGE-B (06855) plans to apply for listing American depositary shares on the Nasdaq Global Select Market (or Nasdaq).

Important Notice:

Health Road (02587) priced at HKD 7.8 per share, with a subscription rate of 34.42 times for the public offering in Hong Kong.

InnoCare (02577) has a public offer price of HKD 30.86 per share and received slight oversubscription in the public offering.

iFlytek Medical Technology (02506) received a subscription rate of 3.66 times for the public offering, with a net fundraising of approximately HKD 0.507 billion for the Global offering.

SSY GROUP (02005): Furosemide injection has obtained the consistency evaluation of quality and efficacy for generic drugs from the National Medical Products Administration.

ASCENTAGE-B (06855) intends to apply for listing American depositary shares on the Nasdaq Global Select Market (or Nasdaq).

HENGTOU SEC (01476) and Huarong Comprehensive Investment plan to inject capital into Xinhua Fund in the form of Cash.

CHINA XLX FERT (01866): The first phase of the compound fertilizer project at the Guangxi base has been successfully put into production.

China Zheshang Bank (02016) plans to increase its capital to Zhiyin Financial Leasing by no more than 1.02 billion yuan.

Kongnaite Optics (02276): Hong Kong Goertek plans to acquire no more than 42.8 million shares of the company.

COUNTRY GARDEN (02007) subsidiary intends to sell approximately 1.56% of Changxin Technology's equity for 2 billion yuan.

VESYNC (02148) received an arrangement from the offeror VICTORY III CO., LTD for privatization and will resume trading on December 30.

Business performance:

YADEA (01585) expects an annual net profit of approximately 1.2 billion to -1.4 billion yuan.

SHENZHENEXPRESS (00548): In November, the revenue from tolls for the outer ring project was 0.101 billion yuan, a decrease of 3.41% year-on-year.

For more details, please refer to 智通财经网().

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment